کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
6103233 | 1211125 | 2014 | 6 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: Research ArticleRestoration of HCV-specific CD8+ T cell function by interferon-free therapy Research ArticleRestoration of HCV-specific CD8+ T cell function by interferon-free therapy](/preview/png/6103233.png)
Background & AimsChronic hepatitis C virus (HCV) infection is characterised by a failure of virus-specific CD8+ T cells that is mainly caused by viral escape and T cell exhaustion. Constant antigen stimulation has been suggested to contribute to HCV-specific CD8+ T cell exhaustion. However, IFN-based therapies failed to recover HCV-specific CD8+ T cell function suggesting that the damage to CD8+ T cells may be permanent even after antigen removal. It was therefore the objective of this study to analyse the impact of inhibition of ongoing viral replication by IFN-free therapy with direct acting antivirals (DAA) on the phenotype and function of HCV-specific CD8+ T cells.MethodsVirus-specific CD8+ T cells obtained from a patient cohort of 51 previously untreated chronically infected patients undergoing IFN-free therapy with a combination of faldaprevir (a protease inhibitor) and deleobuvir (a non-nucleoside polymerase inhibitor) with or without ribavirin were analysed ex vivo and after in vitro expansion at baseline, wk4, wk12, and after treatment.ResultsOur results show the rapid restoration of proliferative HCV-specific CD8+ T cells in the majority of patients with SVR12 within 4Â weeks of therapy suggesting that IFN-free therapy mediated antigen removal may restore CD8+ T cell function.ConclusionsThis study indicates a specific restoration of proliferative HCV-specific CD8+ T cells under IFN-free therapy. This is in contrast to PegIFN-based therapies that have been shown not to restore T cell function during and after chronic infection.
Journal: Journal of Hepatology - Volume 61, Issue 3, September 2014, Pages 538-543